...
首页> 外文期刊>Journal of clinical psychopharmacology >Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: A case report
【24h】

Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: A case report

机译:氟伏沙明解决了度洛西汀相关的迟发性运动障碍:一例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Quetiapine is an atypical antipsychotic approved for treatment of schizophrenia and bipolar depression. It has become an increasingly popular pharmacotherapy for anxiety and insomnia,1 with demonstrated efficacy in treating these conditions. Similar to other medications with sedative and anxiolytic effects, there have been multiple reports of quetiapine misuse. Case reports have documented users embellishing or fabricating symptoms to obtain quetiapine as well as its sale and acquisition through illegitimate channels.
机译:喹硫平是一种非典型抗精神病药,已批准用于治疗精神分裂症和双相抑郁症。它已成为治疗焦虑症和失眠症的一种日益流行的药物疗法,并已证明可有效治疗这些疾病。与具有镇静和抗焦虑作用的其他药物类似,喹硫平滥用也有许多报道。案例报告记录了用户修饰或捏造症状以获取喹硫平以及通过非法渠道进行买卖的行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号